| Contrasting three type 2 diabetes cardiovascular risk equations for east asia with ukpds82 using the IQVIA core diabetes model |
| Author(s): Ramos M1, Monteiro S2, Olivieri AV3, Lamotte M1 |
| Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK 3 IQVIA, Basel, Switzerland |
Publication(s): ISPOR US 2020 Orlando, Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56
|
| Document Type(s): Article, |
| Countries: Asia Pacific, |
C:
Y: |
Diabetes,
2020 |
|
L:
A: |
English
Population Based Study, |
|
 |
| |
| |
| High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study |
| Author(s): Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi |
| Affiliations(s): a
The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA
b
Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA
c
The Walton Centre, Liverpool, UK
d
University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany
e
Parkinson-Klinik Ortenau, Wolfach, Germany
f
Allergan, an AbbVie Company, Irvine, CA, USA
g
IQVIA Real-World Evidence Solutions, Cambridge, MA, USA
h
MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA |
Publication(s): PM R
. 2020 Jan 17. doi: 10.1002/pmrj.12328.
PMID: 31953896 DOI: 10.1002/pmrj.12328
|
| Document Type(s): Article, |
| Countries: Asia Pacific, Europe, USA, |
| Click here for the abstract |
C:
Y: |
Drug Utlization Study, Medication compliance,
2020 |
|
L:
A: |
English
Methodology, Observational study, |
|
|
| |
| |
| Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study |
| Author(s): Gerard E Francisco 1, Wolfgang H Jost 2, Ganesh Bavikatte 3, Daniel S Bandari 4, Simon F T Tang 5, Michael C Munin 6, Joan Largent 7, Aubrey M Adams 8, Aleksej Zuzek 8, Alberto Esquenazi 9 |
| Affiliations(s): 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX.
2Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany.
3The Walton Centre, Liverpool, UK.
4Multiple Sclerosis Center of California & Research Group, Newport Beach, CA.
5Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan.
6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA.
7IQVIA Real-World Evidence Solutions, Cambridge, MA.
8Allergan plc, Irvine, CA.
9MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA. |
Publication(s): PMID: 31953896 PMCID: PMC7687094 DOI: 10.1002/pmrj.12328
|
| Document Type(s): Article, |
| Countries: Asia Pacific, Europe, USA, |
| Click here for the abstract |
C:
Y: |
Neurological disorders,
2020 |
|
L:
A: |
English
Epidemiological study, Observational study, |
|
|
| |
| |
| Three Asian Type 2 Diabetes cardiovascular risk equations simulation using the IQVIA Core Diabetes Model |
| Author(s): Ryo Mitsuo 1, Sven Demiya 1, Adeeb Tawseef 1, Raf De Moor 1, M Ramos, M Lamotte (rwesheorj 1) |
| Affiliations(s): IQVIA HEOR Zaventem Brussels
|
Publication(s): Japan Diabetes Society 2020 Annual Meeting
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, Japan, |
C:
Y: |
Diabetes, Health economics,
2020 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL. |
| Author(s): Ramos M, Monteiro S, Olivieri AV, Lamotte M.
|
| Affiliations(s): IQVIA HEOR Zaventem Brussels
|
Publication(s): ISPOR US 2020 Orlando. Value in Health, Volume 23, Issue 5, S1 (May 2020) Code PDB56
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, |
C:
Y: |
Diabetes, Health economics,
2020 |
|
L:
A: |
English
Clinical setting: Primary care, Cost effectiveness, |
|
|
| |
| |
| Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis |
| Author(s): Prentice M1, Mpima S2, Martinez S2, Nasuti P2, Davda R1, Payne H1 |
| Affiliations(s): 1 University College Hospital, London, UK, 2 IQVIA , London, UK |
| Publication(s): |
| Document Type(s): |
| Countries: Asia Pacific, Europe, |
C:
Y: |
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia |
| Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 |
| Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA |
Publication(s): JCO ( ASCO 2018)
|
| Document Type(s): Abstract, |
| Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK, |
| Click here for the abstract |
C:
Y: |
Oncology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES |
| Author(s): Takeno S1, Tanaka S1, Saijo N1 Nasuti P2 |
| Affiliations(s): 1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK |
Publication(s): ISPOR 2018 APAC
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, Europe, |
C:
Y: |
Oncology,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| High Prevalence of Comorbidities and Contraindicated Medications in Hepatitis C Patients in Japan |
| Author(s): Tsutsumi, T., Kruger, E., Tan, S. C., Yotsuyanagi, H. |
| Affiliations(s): QuintilesIMS Health Singapore |
Publication(s): Journal of Viral Hepatitis
|
| Document Type(s): Article, |
| Countries: Asia Pacific, |
C:
Y: |
Infectious disease,
2017 |
|
L:
A: |
English
|
|
|
| |
| |
| Evaluating Renal Cell Carcinoma treatment options using real world data: findings from an oncology survey across seven countries |
| Author(s): S. Mpima, S. Menon, P. Nasuti, H. Mistry |
| Affiliations(s): IQVIA London UK |
Publication(s): ESMO - ImmunoOncology
|
| Document Type(s): Poster, |
| Countries: Asia Pacific, Europe, |
C:
Y: |
Oncology,
2017 |
|
L:
A: |
English
|
|
|
| |
| |
 1 of 3 
|
